Formulation and in vitro characterization of raloxifene nanoemulgel for improved skin permeation

Raloxifene, an estrogen receptor modulator, has poor bioavailability due to extensive metabolism and poor solubility. The present work aimed to enhance skin permeation of raloxifene for systematic delivery. Raloxifene nanoemulsion has been developed using various combination of sunflower oil and tw...

Full description

Bibliographic Details
Main Authors: Chatterjee, Bappaditya, Mohammed Hasan, Ali Ebrahim
Format: Conference or Workshop Item
Language:English
English
English
Published: 2018
Subjects:
Online Access:http://irep.iium.edu.my/68359/
http://irep.iium.edu.my/68359/1/ICPRP%202018.pdf
http://irep.iium.edu.my/68359/13/359%20ICPRP%20PROG%20BOOK.pdf
http://irep.iium.edu.my/68359/14/359%20Presentation%20Bappa.pdf
id iium-68359
recordtype eprints
spelling iium-683592018-12-10T06:11:23Z http://irep.iium.edu.my/68359/ Formulation and in vitro characterization of raloxifene nanoemulgel for improved skin permeation Chatterjee, Bappaditya Mohammed Hasan, Ali Ebrahim RS192 Materia Medica-Pharmaceutical Technology Raloxifene, an estrogen receptor modulator, has poor bioavailability due to extensive metabolism and poor solubility. The present work aimed to enhance skin permeation of raloxifene for systematic delivery. Raloxifene nanoemulsion has been developed using various combination of sunflower oil and tween 20- transcutol (surfactant-co-surfactant) followed by the in-vitro characterizations (pH, zeta potential, globule size, thermodynamic stability). Optimized nanoemulsion was converted to nanoemulgel by incorporating carbopol 940 (3% (w/v), pH 6.5) followed by rheology. spreadability, drug loading, toxicity, and ex-vivo permeation studies. Selected formulations resulted in 3.80-3.93 (pH), 24.98-33.8 mV (zeta potential) and 153.10-208.20 nm (globule size) with polydispersity index (<0.259). Developed gel has shown viscoelastic behaviour with acceptable viscosity and spreadability. Drug loading in selected gel, were above 91.41%. Ex-vivo permeation study through rat skin showed significantly higher (>2.5 times) permeation of raloxifene compared to normal gel and solution. FTiR and DSC study revealed alteration of skin fluidity that promotes drug permeation. Nanoemulgel could be a better alternative to deliver raloxifene directly to the circulation through skin due to its nanoscaled size, presence of surfactant and enhanced retention of skin. 2018-10 Conference or Workshop Item NonPeerReviewed application/pdf en http://irep.iium.edu.my/68359/1/ICPRP%202018.pdf application/pdf en http://irep.iium.edu.my/68359/13/359%20ICPRP%20PROG%20BOOK.pdf application/pdf en http://irep.iium.edu.my/68359/14/359%20Presentation%20Bappa.pdf Chatterjee, Bappaditya and Mohammed Hasan, Ali Ebrahim (2018) Formulation and in vitro characterization of raloxifene nanoemulgel for improved skin permeation. In: International Conference on Pharmaceutical Research and Practice, 5th-6th October 2018, Yogjakarta, Indonesia.
repository_type Digital Repository
institution_category Local University
institution International Islamic University Malaysia
building IIUM Repository
collection Online Access
language English
English
English
topic RS192 Materia Medica-Pharmaceutical Technology
spellingShingle RS192 Materia Medica-Pharmaceutical Technology
Chatterjee, Bappaditya
Mohammed Hasan, Ali Ebrahim
Formulation and in vitro characterization of raloxifene nanoemulgel for improved skin permeation
description Raloxifene, an estrogen receptor modulator, has poor bioavailability due to extensive metabolism and poor solubility. The present work aimed to enhance skin permeation of raloxifene for systematic delivery. Raloxifene nanoemulsion has been developed using various combination of sunflower oil and tween 20- transcutol (surfactant-co-surfactant) followed by the in-vitro characterizations (pH, zeta potential, globule size, thermodynamic stability). Optimized nanoemulsion was converted to nanoemulgel by incorporating carbopol 940 (3% (w/v), pH 6.5) followed by rheology. spreadability, drug loading, toxicity, and ex-vivo permeation studies. Selected formulations resulted in 3.80-3.93 (pH), 24.98-33.8 mV (zeta potential) and 153.10-208.20 nm (globule size) with polydispersity index (<0.259). Developed gel has shown viscoelastic behaviour with acceptable viscosity and spreadability. Drug loading in selected gel, were above 91.41%. Ex-vivo permeation study through rat skin showed significantly higher (>2.5 times) permeation of raloxifene compared to normal gel and solution. FTiR and DSC study revealed alteration of skin fluidity that promotes drug permeation. Nanoemulgel could be a better alternative to deliver raloxifene directly to the circulation through skin due to its nanoscaled size, presence of surfactant and enhanced retention of skin.
format Conference or Workshop Item
author Chatterjee, Bappaditya
Mohammed Hasan, Ali Ebrahim
author_facet Chatterjee, Bappaditya
Mohammed Hasan, Ali Ebrahim
author_sort Chatterjee, Bappaditya
title Formulation and in vitro characterization of raloxifene nanoemulgel for improved skin permeation
title_short Formulation and in vitro characterization of raloxifene nanoemulgel for improved skin permeation
title_full Formulation and in vitro characterization of raloxifene nanoemulgel for improved skin permeation
title_fullStr Formulation and in vitro characterization of raloxifene nanoemulgel for improved skin permeation
title_full_unstemmed Formulation and in vitro characterization of raloxifene nanoemulgel for improved skin permeation
title_sort formulation and in vitro characterization of raloxifene nanoemulgel for improved skin permeation
publishDate 2018
url http://irep.iium.edu.my/68359/
http://irep.iium.edu.my/68359/1/ICPRP%202018.pdf
http://irep.iium.edu.my/68359/13/359%20ICPRP%20PROG%20BOOK.pdf
http://irep.iium.edu.my/68359/14/359%20Presentation%20Bappa.pdf
first_indexed 2023-09-18T21:37:01Z
last_indexed 2023-09-18T21:37:01Z
_version_ 1777412888861868032